Cargando…

Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging

BCAT1 (branched-chain amino acid trasaminase1) expression is necessary for the progression of IDH1 wild-type (WT) glioblastoma multiforme (GBM), which is known to be associated with aggressive tumors. The purpose of our study is to investigate the bevacizumab resistance increased by the expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hye Rim, Hong, Bora, Kim, Hyeonjin, Park, Chul-Kee, Park, Sung-Hye, Park, Sunghyouk, Choi, Seung Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342501/ https://www.ncbi.nlm.nih.gov/pubmed/27626306 http://dx.doi.org/10.18632/oncotarget.11901

Ejemplares similares

BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients
por: Cho, Hye Rim, et al.
Publicado: (2017)

Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI
por: Cho, Hye Rim, et al.
Publicado: (2019)

Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival
por: Chaurasia, Ajay, et al.
Publicado: (2016)

The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations
por: Siakallis, Loizos, et al.
Publicado: (2023)

Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status()
por: Myung, Jae Kyung, et al.
Publicado: (2014)

On the Utility of Short Echo Time (TE) Single Voxel 1H–MRS in Non–Invasive Detection of 2–Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel
por: Heo, Hwon, et al.
Publicado: (2016)

Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas
por: Kim, Ja Eun, et al.
Publicado: (2015)

Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2
por: Fu, Fei, et al.
Publicado: (2022)

An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy
por: Li, MuLan, et al.
Publicado: (2011)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

Cerebral Blood Volume Calculated by Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging: Preliminary Correlation Study with Glioblastoma Genetic Profiles
por: Ryoo, Inseon, et al.
Publicado: (2013)

Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
por: Park, Chul-Kee, et al.
Publicado: (2015)

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
por: Nam, Yoonhee, et al.
Publicado: (2023)

Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis
por: Cho, Hye Rim, et al.
Publicado: (2018)

Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging
por: Cho, Hye Rim, et al.
Publicado: (2019)

Macrophages Homing to Metastatic Lymph Nodes Can Be Monitored with Ultrasensitive Ferromagnetic Iron-Oxide Nanocubes and a 1.5T Clinical MR Scanner
por: Cho, Hye Rim, et al.
Publicado: (2012)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma
por: Kim, Sojin, et al.
Publicado: (2017)

BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages
por: Ko, Jeong-Hun, et al.
Publicado: (2020)

Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
por: van Noorden, Cornelis J.F., et al.
Publicado: (2021)

Image-to-image generative adversarial networks for synthesizing perfusion parameter maps from DSC-MR images in cerebrovascular disease
por: Kossen, Tabea, et al.
Publicado: (2023)

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
por: Haider, Ali S., et al.
Publicado: (2023)

Investigating the value of radiomics stemming from DSC quantitative biomarkers in IDH mutation prediction in gliomas
por: Ioannidis, Georgios S., et al.
Publicado: (2023)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
por: Marchi, Francesco, et al.
Publicado: (2020)

Perfusion-weighted software written in Python for DSC-MRI analysis
por: Fernández-Rodicio, Sabela, et al.
Publicado: (2023)

Multiparametric magnetic resonance imaging features of a canine glioblastoma model
por: Lee, Seunghyun, et al.
Publicado: (2021)

Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas
por: Moon, Hye Hyeon, et al.
Publicado: (2021)

Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
por: Wang, Zheng, et al.
Publicado: (2013)

Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues
por: Jedi, Maher, et al.
Publicado: (2018)

Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
por: Krell, Daniel, et al.
Publicado: (2011)

BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases
por: Papathanassiu, Adonia E., et al.
Publicado: (2017)

BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma
por: Xu, Meng, et al.
Publicado: (2016)

Data mining of the expression and regulatory role of BCAT1 in hepatocellular carcinoma
por: Zou, Haifan, et al.
Publicado: (2019)

IDH1 mutations in a Brazilian series of Glioblastoma
por: Uno, Miyuki, et al.
Publicado: (2011)

Phosphorous Magnetic Resonance Spectroscopy and Molecular Markers in IDH1 Wild Type Glioblastoma
por: Galijašević, Malik, et al.
Publicado: (2021)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
por: Yoon, Seon-Jin, et al.
Publicado: (2020)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients
por: Stancheva, Gergana, et al.
Publicado: (2014)

Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program
por: Park, Junseong, et al.
Publicado: (2023)

Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma
por: Cao, Wenjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ig9c6ga5orlfu9f4tq8eg81g4